Mr Kerry Hueter, RPH, CFTS | |
2547 Warm Springs Rd, Warm Springs, AR 72478-9113 | |
(870) 647-8080 | |
Not Available |
Full Name | Mr Kerry Hueter |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 2547 Warm Springs Rd, Warm Springs, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154318723 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 07155 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Kerry Hueter, RPH, CFTS 2547 Warm Springs Rd, Warm Springs, AR 72478-9113 Ph: () - | Mr Kerry Hueter, RPH, CFTS 2547 Warm Springs Rd, Warm Springs, AR 72478-9113 Ph: (870) 647-8080 |
News Archive
Researchers employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease.
Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, announced today that the Company closed its previously announced private placement with investors including Oracle Investment Management, Jack W. Schuler, Birchview Fund LLC and several Vermillion directors. Total proceeds were $10.5 million, before offering expenses.
With its roster of corporate sponsors and the pink ribbons that lend a halo to almost any kind of product you can think of, the Susan G. Komen for the Cure foundation has a longstanding reputation as a staunch protector of women's health. That reputation suffered a grievous, perhaps mortal, wound this week from the news that Komen, the world's largest breast cancer organization, decided to betray that mission.
The status of ongoing negotiations to raise the debt ceiling changes daily, and news outlets report on the political and policy dynamics in play.
Meda has signed a long-term license agreement with the specialty division of Mylan Inc., Dey Pharma, L.P., for exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly (often within a couple of minutes) and may be life-threatening.
› Verified 7 days ago